stockrowCONMED Corporation (CNMD) vs NovoCure Limited (NVCR)
- CONMED Corporation CNMD 51.69 −2.16%
- NovoCure Limited NVCR 13.47 −0.59%
CONMED Corporation and NovoCure Limited are both Medical Devices companies. CONMED Corporation and NovoCure Limited are of similar size ($1.6B and $1.6B). NovoCure Limited has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 21.7×. NovoCure Limited grew revenue faster over the last twelve months: 12.9% against 1.62%. CONMED Corporation has the higher net margin (5.36% vs −16.8%) and the higher return on invested capital (4.64% vs −106.1%). Across the 19 metrics below, CONMED Corporation leads on 13 and NovoCure Limited on 6.
Valuation
Profitability
| Metric | CNMD | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.57% | 77.02% | 57.76% |
| Operating margin | 9.90% | (17.17%) | (15.07%) |
| Net margin | 5.36% | (16.78%) | (14.45%) |
| Free cash flow margin | 9.69% | (3.39%) | (3.88%) |
| Return on equity | 7.10% | (35.18%) | (10.35%) |
| Return on assets | 3.17% | (11.12%) | (17.26%) |
| Return on invested capital | 4.64% | (106.10%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack